US Patent Issued to Regeneron Pharmaceuticals on Nov. 18 for "Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors" (New York Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,241, issued on Nov. 18, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors" was invented by Julie Horowitz (Tarrytown, N.Y.) and Aris Baras (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of treating patients having a respiratory disorder, methods of identifying subjects having an increased risk of developing a respiratory disorder, and methods of detecting human Arachidonate 15-Lipoxygenase (ALOX15) variant nucleic acid molecules and variant polypeptides."

The patent was filed on Dec. 23, ...